Contribution of a common single-nucleotide polymorphism to the genetic predisposition for erythropoietic protoporphyria

American Journal of Human Genetics

Volumn 78, Issue 1, 2006, Pages 2-14

  Gouya, Laurent ^a,c   Martin Schmitt, Caroline ^a,c,d   Robreau, Anne Marie ^a,c   Austerlitz, Frédéric ^e   Da Silva, Vasco ^a,c   Brun, Patrick ^c   Simonin, Sylvie ^a   Lyoumi, Saïd ^c   Grandchamp, Bernard ^b,c   Beaumont, Carole ^c   Puy, Hervé ^a,c,d   Deybach, Jean Charles ^a,c  

^a INSERM   (France)

^b BICHAT HOSPITAL   (France)

^c HÔPITAL LOUIS MOURIER   (France)

^d LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^e UNIVERSITÉ PARIS SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FERROCHELATASE;

AGE; ALLELE; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CALCULATION; CAUCASIAN; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; ERYTHROPOIETIC PROTOPORPHYRIA; FRANCE; GENE FREQUENCY; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC SELECTION; HAPLOTYPE; HEME SYNTHESIS; HUMAN; HUMAN CELL; INHERITANCE; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHOTOSENSITIVITY; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

PAN;

EID: 29244454253     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/498620     Document Type: Article

References (47)

1. Anderson KE, Sassa S, Bishop DF, Desnick RJ (2001) Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease. 8th ed. McGraw-Hill, New York, pp 2961-3062
2. Aplin C, Whatley SD, Thompson P, Hoy T, Fisher P, Singer C, Lovell CR, Elder GH (2001) Late-onset erythropoietic porphyria caused by a chromosome 18q deletion in erythroid cells. J Invest Dermatol 117:1647-1649
3. Austerlitz F, Kalaydjieva L, Heyer E (2003) Detecting population growth, selection and inherited fertility from haplotypic data in humans. Genetics 165:1579-1586
4. Bloomer JR (1988) The liver in protoporphyria. Hepatology 8:402-407
5. Bonkowsky HL, Bloomer JR, Ebert PS, Mahoney MJ (1975) Heme synthetase deficiency in human protoporphyria: demonstration of the defect in liver and cultured skin fibroblasts. J Clin Invest 56:1139-1148
6. Chen FP, Risheg H, Liu Y, Bloomer J (2002) Ferrochelatase gene mutations in erythropoietic protoporphyria: focus on liver disease. Cell Mol Biol (Noisy-le-grand) 48:83-89
7. Childs S, Weinstein BM, Mohideen MA, Donohue S, Bonkovsky H, Fishman MC (2000) Zebrafish dracula encodes ferrochelatase and its mutation provides a model for erythropoietic protoporphyria. Curr Biol 10:1001-1004
8. Deacon AC, Elder GH (2001) ACP best practice no 165: front line tests for the investigation of suspected porphyria. J Clin Pathol 54:500-507
9. Delaunay J (2002) Molecular basis of red cell membrane disorders. Acta Haematol 108:210-218
10. Deybach JC, Da Silva V, Pasquier Y, Nordmann Y (1986) Ferrochelatase in human erythropoietic protoporphyria: the first case of a homozygous form of the enzyme deficiency. In: Nordmann Y (ed) Porphyrines and porphyries. John Libbey, Paris, pp 163-173
11. Doss MO, Frank M (1989) Hepatobiliary implications and complications in protoporphyria, a 20-year study. Clin Biochem 22:223-229
12. Emison ES, McCallion AS, Kashuk CS, Bush RT, Grice E, Lin S, Portnoy ME, Cutler DJ, Green ED, Chakravarti A (2005) A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk. Nature 434:857-863
13. Goerz G, Bunselmeyer S, Bolsen K, Schurer NY (1996) Ferrochelatase activities in patients with erythropoietic protoporphyria and their families. Br J Dermatol 134:880-885
14. Gouya L, Deybach JC, Lamoril J, Da Silva V, Beaumont C, Grandchamp B, Nordmann Y (1996) Modulation of the phenotype in dominant erythropoietic protoporphyria by a low expression of the normal ferrochelatase allele. Am J Hum Genet 58:292-299
15. Gouya L, Puy H, Lamoril J, Da Silva V, Grandchamp B, Nordmann Y, Deybach JC (1999) Inheritance in erythropoietic protoporphyria: a common wild-type ferrochelatase allelic variant with low expression accounts for clinical manifestation. Blood 93:2105-2110
16. Gouya L, Puy H, Robreau AM, Bourgeois M, Lamoril J, Da Silva V, Grandchamp B, Deybach JC (2002) The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wild-type FECH. Nat Genet 30:27-28
17. Kivisild T, Bamshad MJ, Kaldma K, Metspalu M, Metspalu E, Reidla M, Laos S, Parik J, Watkins WS, Dixon ME, Papiha SS, Mastana SS, Mir MR, Ferak V, Villems R (1999) Deep common ancestry of indian and western-Eurasian mitochondrial DNA lineages. CurrBiol 9:1331-1334
18. Kondo M, Yano Y, Shirataka M, Urata G, Sassa S (2004) Porphyrias in Japan: compilation of all cases reported through 2002. Int J Hematol 79:448-456
19. Labuda D, Zietkiewicz F, Labuda M (1997) The genetic clock and the age of the founder effect in growing populations: a lesson from the French Canadians and Ashkenazim. Am J Hum Genet 61:768-771
20. Lahr MM, Foley RA (1998) Towards a theory of modern human origins: geography, demography, and diversity in recent human evolution. Am J Phys Anthropol Suppl 27:137-176
21. Lamoril J, Boulechfar S, de Verneuil H, Grandchamp B, Nordmann Y, Deybach JC (1991) Human erythropoietic protoporphyria: two point mutations in the ferrochelatase gene. Biochem Biophys Res Commun 181:594-599
22. Li FM, Lim CK, Peters TJ (1987) An HPLC assay for rat liver ferrochelatase activity. Biomed Chromatogr 2:164-168
23. Magness ST, Maeda N, Brenner DA (2002) An exon 10 deletion in the mouse ferrochelatase gene has a dominant-negative effect and causes mild protoporphyria. Blood 100:1470-1477
24. Meerman L (2000) Erythropoietic protoporphyria: an overview with emphasis on the liver. Scand J Gastroenterol Suppl (232):79-85
25. Najahi-Missaoui W, Dailey HA (2005) Production and characterization of erythropoietic protoporphyric heterodimeric terrochelatases. Blood 106:1098-1104
26. Nordmann Y, Deybach JC (1990) Human hereditary porphyrias. In: Dailey HA (ed) Biosynthesis of heme and chlorophylls. McGraw-Hill, New York, pp 491-542
27. Norris PG, Nunn AV, Hawk JL, Cox TM (1990) Genetic heterogeneity in erythropoietic protoporphyria: a study of the enzymatic defect in nine affected families. J Invest Dermatol 95:260-263
28. Ohgari Y, Sawamoto M, Yamamoto M, Kohno H, Taketani S (2005) Ferrochelatase consisting of wild-type and mutated subunits from patients with a dominant-inherited disease, erythropoietic protoporphyria, is an active but unstable dimer. Hum Mol Genet 14:327-334
29. Onaga Y, Ido A, Uto H, Hasuike S, Kusumoto K, Moriuchi A, Numata M, Nagata K, Hori T, Hayashi K, Tsubouchi H (2004) Hypermethylation of the wild-type ferrochelatase allele is closely associated with severe liver complication in a family with erythropoietic protoporphyria. Biochem Biophys Res Commun 321:851-858
30. Poh-Fitzpatrick MB, Wang X, Anderson KE, Bloomer JR, Bolwell B, Lichtin AE (2002) Erythropoietic protoporphyria: altered phenotype after bone marrow transplantation for myelogenous leukemia in a patient heteroallelic for ferrochelatase gene mutations. J Am Acad Dermatol 46:861-866
31. Povey S, Lovering R, Bruford E, Wright M, Lush M, Wain H (2001) The HUGO Gene Nomenclature Committee (HGNC). Hum Genet 109:678-680
32. Risheg H, Chen FP, Bloomer JR (2003) Genotypic determinants of phenotype in North American patients with erythropoietic protoporphyria. Mol Genet Metab 80:196-206
33. Rossi E, Costin KA, Garcia-Webb P (1988) Ferrochelatase activity in human lymphocytes, as quantified by a new high-performance liquid-chromatographic method. Clin Chem 34:2481-2485
34. Rüfenacht UB, Gouya L, Schneider-Yin X, Puy H, Schafer BW, Aquaron R, Nordmann Y, Minder EI, Deybach JC (1998) Systematic analysis of molecular defects in the ferrochelatase gene from patients with erythropoietic protoporphyria. Am J Hum Genet 62:1341-1352
35. Ruth GR, Schwartz S, Stephenson B (1977) Bovine protoporphyria: the first nonhuman model of this hereditary photosensitizing disease. Science 198:199-201
36. Sarkany RP, Alexander GJ, Cox TM (1994) Recessive inheritance of erythropoietic protoporphyria with liver failure. Lancet 344:958-959
37. Schneider S, Kueffer J-M, Roessli D, Excoffier L (1997) Arlequin version 1.1: a software for population genetic data analysis. Genetics and Biometry Laboratory, University of Geneva, Geneva
38. Schneider-Yin X, Gouya L, Meier-Weinand A, Deybach JC, Minder EI (2000) New insights into the pathogenesis of erythropoietic protoporphyria and their impact on patient care. Eur J Pediatr 159:719-725
39. Schoenfeld N, Mamet R, Minder EI, Schneider-Yin X (2003) A "null allele" mutation is responsible for erythropoietic protoporphyria in an Israeli patient who underwent liver transplantation: relationships among biochemical, clinical, and genetic parameters. Blood Cells Mol Dis 30:298-301
40. Todd DJ (1994) Erythropoietic protoporphyria. Br J Dermatol 131:751-766
41. Tutois S, Montagutelli X, Da Silva V, Jouault H, Rouyer-Fessard P, Leroy-Viard K, Guenet JL, Nordmann Y, Beuzard Y, Deybach JC (1991) Erythropoietic protoporphyria in the house mouse: a recessive inherited ferrochelatase deficiency with anemia, photosensitivity, and liver disease. J Clin Invest 88:1730-1736
42. Went LN, Klasen EC (1984) Genetic aspects of erythropoietic protoporphyria. Ann Hum Genet 48:105-117
43. Whatley SD, Mason NG, Khan M, Zamiri M, Badminton MN, Missaoui WN, Dailey TA, Dailey HA, Douglas WS, Wainwright NJ, Elder GH (2004) Autosomal recessive erythropoietic protoporphyria in the United Kingdom: prevalence and relationship to liver disease. J Med Genet 41:e105
44. Wiman A, Floderus Y, Harper P (2003) Novel mutations and phenotypic effect of the splice site modulator IVS3-48C in nine Swedish families with erythropoietic protoporphyria. J Hum Genet 48:70-76
45. Yasui Y, Muranaka S, Tahara T, Shimizu R, Watanabe S, Horie Y, Nanba E, Uezato H, Takamiyagi A, Taketani S, Akagi R (2002) A new ferrochelatase mutation combined with low expression alleles in a Japanese patient with erythropoietic protoporphyria. Clin Sci (Lond) 102:501-506
46. Yotsumoto S, Shimada S, Terasaki K, Taketani S, Kobayashi K, Saheki T, Kanzaki T (2001) A novel A(-4)-to-G acceptor splice site mutation leads to three bases insertion in ferrochelatase mRNA in a patient with erythropoietic protoporphyria. J Invest Dermatol 117:159-161
47. Zietkiewicz E, Yotova V, Gehl D, Wambach T, Arrieta I, Batzer M, Cole DE, Hechtman P, Kaplan F, Modiano D, Moisan JP, Michalski R, Labuda D (2003) Haplotypes in the dystrophin DNA segment point to a mosaic origin of modern human diversity. Am J Hum Genet 73:994-1015